185 related articles for article (PubMed ID: 12518657)
1. [Neuroprotection by aspirin in cerebrovascular pathology].
Lorenzo Fernández P
An R Acad Nac Med (Madr); 2002; 119(2):311-20; discussion 320-6. PubMed ID: 12518657
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation.
De Cristóbal J; Cárdenas A; Lizasoain I; Leza JC; Fernández-Tomé P; Lorenzo P; Moro MA
Stroke; 2002 Jan; 33(1):261-7. PubMed ID: 11779920
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats.
De Cristóbal J; Moro MA; Dávalos A; Castillo J; Leza JC; Camarero J; Colado MI; Lorenzo P; Lizasoain I
J Neurochem; 2001 Oct; 79(2):456-9. PubMed ID: 11677274
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia.
Pérez-Asensio FJ; Hurtado O; Burguete MC; Moro MA; Salom JB; Lizasoain I; Torregrosa G; Leza JC; Alborch E; Castillo J; Knowles RG; Lorenzo P
Neurobiol Dis; 2005 Mar; 18(2):375-84. PubMed ID: 15686966
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia.
Berger C; Stauder A; Xia F; Sommer C; Schwab S
Exp Neurol; 2008 Apr; 210(2):543-8. PubMed ID: 18187132
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke.
Hurtado O; De Cristóbal J; Sánchez V; Lizasoain I; Cárdenas A; Pereira MP; Colado MI; Leza JC; Lorenzo P; Moro MA
FASEB J; 2003 Nov; 17(14):2082-4. PubMed ID: 14500556
[TBL] [Abstract][Full Text] [Related]
8. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
Lestage P; Lockhart B; Roger A
Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
[TBL] [Abstract][Full Text] [Related]
9. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.
Alvarez-Sabín J; Penalba A; Quintana M; Krupinski J; García-Bonilla L; Montaner J
Cerebrovasc Dis; 2009; 28(4):371-7. PubMed ID: 19641312
[TBL] [Abstract][Full Text] [Related]
10. Oxygen-glucose deprivation decreases glutathione levels and glutamate uptake in rat hippocampal slices.
Brongholi K; Souza DG; Bainy AC; Dafre AL; Tasca CI
Brain Res; 2006 Apr; 1083(1):211-8. PubMed ID: 16530736
[TBL] [Abstract][Full Text] [Related]
11. Profile of glutamate uptake and cellular viability in hippocampal slices exposed to oxygen and glucose deprivation: developmental aspects and protection by guanosine.
Thomazi AP; Boff B; Pires TD; Godinho G; Battú CE; Gottfried C; Souza DO; Salbego C; Wofchuk ST
Brain Res; 2008 Jan; 1188():233-40. PubMed ID: 18053975
[TBL] [Abstract][Full Text] [Related]
12. Targets of cytoprotection in acute ischemic stroke: present and future.
Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa.
Labrande C; Velly L; Canolle B; Guillet B; Masmejean F; Nieoullon A; Pisano P
Neuroscience; 2006; 137(1):231-9. PubMed ID: 16289353
[TBL] [Abstract][Full Text] [Related]
14. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
[TBL] [Abstract][Full Text] [Related]
15. GIF-0173 protects against cerebral infarction through DP1 receptor activation.
Thura M; Hokamura K; Yamamoto S; Maeda M; Furuta K; Suzuki M; Ibaraki K; Umemura K
Exp Neurol; 2009 Oct; 219(2):481-91. PubMed ID: 19576888
[TBL] [Abstract][Full Text] [Related]
16. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid.
Khansari PS; Halliwell RF
Neurochem Int; 2009 Dec; 55(7):683-8. PubMed ID: 19563851
[TBL] [Abstract][Full Text] [Related]
17. [Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
Dézsi L; Kis-Varga I; Nagy J; Komlódi Z; Kárpáti E
Acta Pharm Hung; 2002; 72(2):84-91. PubMed ID: 12498034
[TBL] [Abstract][Full Text] [Related]
18. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
[TBL] [Abstract][Full Text] [Related]
19. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
20. Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia.
Pignataro G; Simon RP; Xiong ZG
Brain; 2007 Jan; 130(Pt 1):151-8. PubMed ID: 17114797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
